| Pfizer Files With FDA For Review Of Axitinib For Patients With Advanced RCC - RTT News |
|
|
RTT News (RTTNews) - Pfizer Inc. (PFE: News ) announced that the US Food and Drug Administration, or FDA, has accepted the company's filing for standard review of axitinib for patients with advanced renal cell carcinoma, or RCC. Pfizer noted that the submission ... Pfizer Files With The FDA For Review Of Axitinib For Patients With Advanced ... Business Wire (press release) PFIZER : Files With The FDA For Review Of Axitinib For Patients With Advanced ... 4-traders (press release) Pfizer Files With The FDA For Review Of Axitinib For Patients With Advanced |